Siddhartha Bhoopathy

Title: Siddhartha Bhoopathy: Innovator in Pharmaceutical Bioequivalence

Introduction

Siddhartha Bhoopathy is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of bioequivalence. His work focuses on ensuring that drug formulations meet necessary standards for efficacy and safety.

Latest Patents

Siddhartha holds a patent for a method titled "Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (RLD)." This invention provides innovative methods for determining the in vitro bioequivalence of a sucralfate suspension sample compared to a reference listed drug. His patent is a crucial advancement in the pharmaceutical industry, ensuring that patients receive effective medications.

Career Highlights

Siddhartha Bhoopathy is currently associated with Clayton Pharmaceuticals, LLC, where he applies his expertise in pharmaceutical sciences. His role involves research and development, focusing on improving drug formulations and ensuring compliance with regulatory standards. His dedication to innovation has positioned him as a valuable asset in the pharmaceutical sector.

Collaborations

Siddhartha collaborates with various professionals in the industry, including his coworker Ami C Patel. Together, they work on projects that aim to enhance drug delivery systems and improve patient outcomes.

Conclusion

Siddhartha Bhoopathy's contributions to pharmaceutical bioequivalence highlight his commitment to advancing healthcare through innovation. His patent and work at Clayton Pharmaceuticals, LLC, reflect his dedication to improving drug safety and efficacy.